Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06747091 · ClinicalTrials.gov registry record · NA
ARIADNE Clinical Trial
A NA study of Persistent Atrial Fibrillation, sponsored by Stavros E Mountantonakis.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 3
- Study locations
NCT06747091 is a NA study of Persistent Atrial Fibrillation that is actively recruiting participants, run by Stavros E Mountantonakis. The registered enrollment target is 60 participants, below the 1,256-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT06747091, a NA study of Persistent Atrial Fibrillation, is actively recruiting participants, sponsored by Stavros E Mountantonakis.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 3
- Study locations
Study Summary
A prospective multi-arm parallel group randomized clinical trial to compare the efficacy of three ablation strategies in patients with persistent atrial fibrillation using using a lattice-tip catheter that can switch between RFA and PFA energy. The incremental benefit of posterior wall isolation (PWI) and mitral isthmus ablation may contribute to greater freedom from atrial fibrillation at twelve months.
Conditions Studied
Interventions
- PROCEDURE Catheter Ablation
Study Locations (3)
New York
- North Shore University Hospital - Manhasset
- Long Island Jewish Medical Center - New Hyde Park
- Kristie Coleman - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-03-18 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06747091
The ClinicalTrials.gov registry entry for NCT06747091 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,256-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (95% lower). The listed sponsor is Stavros E Mountantonakis, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Persistent Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Catheter Ablation is the first listed.
NCT06747091 reports 3 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06747091 about?
NCT06747091 is a clinical study titled "ARIADNE Clinical Trial". A prospective multi-arm parallel group randomized clinical trial to compare the efficacy of three ablation strategies in patients with persistent atrial fibrillation using using a lattice-tip catheter that can switch between RFA and PFA energy. The incremental benefit of posterior wall isolation (PW...
What is the current status of trial NCT06747091?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-03-18. Estimated completion is 2027-03-01.
What conditions does trial NCT06747091 study?
This clinical trial studies the following conditions: Persistent Atrial Fibrillation.
What interventions are being tested in trial NCT06747091?
The interventions under investigation include: Catheter Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT06747091?
This trial is sponsored by Stavros E Mountantonakis, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06747091 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Persistent Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endocardial Mapping With the CoreMap EP Mapping System
RECRUITING · NA
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
Medtronic Terminate AF Study
RECRUITING · NA
-
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
RECRUITING · NA
-
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
ACTIVE NOT RECRUITING · NA
-
AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.